United States · FDA National Drug Code directory
RANOLAZINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 77771-423_2db3da6f-14f6-4c55-ad22-55e475ad9f09
- Product NDC
- 77771-423
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- RANOLAZINE
- Labeler
- Radha Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250630
- Source listing expiry
- 20271231
Source-listed ingredients
- RANOLAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (77771-423-60) · 77771-423-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →